FEB 26, 2019 11:00 AM PST

Osteosarcoma research

Speaker
  • Post-doctoral research associate, The University of Sheffield Medical School
    Biography
      Luke Tattersall graduated with a First Class honours degree in Biomedical Sciences from Sheffield Hallam University with a years industrial placement in 2015. Since then Luke has worked on a Bone Cancer Research Trust funded PhD Scholarship in the lab of Professor Allie Gartland at the University of Sheffield Medical School Department of Oncology and Metabolism, focusing on osteosarcoma research. He submitted his PhD thesis in January 2019. During his PhD he has received 3 awards from the Bone Research Society, carried out a travelling fellowship at the University of Ferrara Italy, contributed towards a published book chapter, and was an invited speaker at the International Purine meeting in Brazil. Luke is now a post-doctoral research associate continuing research into osteosarcoma again at the University of Sheffield Medical School and has research experience with both in vitro and in vivo preclinical models of the disease.

    Abstract
    DATE:  February 26, 2019
    TIME:  11:00am PST, 2:00pm EST
     
    Osteosarcoma is the most common type of primary bone cancer affecting adolescents and children attributed to rapid bone growth and turnover with a peak incidence at 18 years old. it is a rare incurable and often fatal disease. The current osteosarcoma treatments include standard chemotherapy, limb salvage surgery or amputation. The 5-year relative survival rate is 70% for localized forms, however, metastasis is present in about one fifth to one quarter of patients at diagnosis, which then contributes to a 5-year survival rate of around 20%. The survival statistics have remained constant with no advances in treatment options for decades highlighting the need for new therapeutic options. 
     
    Learning Objectives:
    • An overview of osteosarcoma disease
    • An overview of osteosarcoma research & preclinical models 
     
    LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

    Show Resources
    You May Also Like
    JAN 23, 2020 9:00 AM PST
    C.E. CREDITS
    JAN 23, 2020 9:00 AM PST
    DATE: January 23, 2020 TIME: 9:00am PST, 12:00pm EST...
    APR 07, 2020 8:00 AM PDT
    C.E. CREDITS
    APR 07, 2020 8:00 AM PDT
    DATE: April 7, 2020 TIME: 8:00am PT, 11:00am ET This webinar sets out to establish why quality control is key to robust, reliable, reproducible science. We will look at best practice criteri...
    FEB 25, 2020 9:00 AM PST
    C.E. CREDITS
    FEB 25, 2020 9:00 AM PST
    Learn about how to generate a small scale CAR-T workflow using ThermoFisher products See detailed characterization tools that can be utilized and applied in a CAR-T workflow...
    MAR 03, 2020 9:00 AM JST
    C.E. CREDITS
    MAR 03, 2020 9:00 AM JST
    DATE: March 3, 2020 TIME: 9:00am JST A major limitation in the ex vivo expansion of harvested human hematopoietic stem-progenitor cells (HSPCs) is the rapid differentiation of HSPCs at the e...
    MAY 08, 2020 10:00 AM PDT
    C.E. CREDITS
    MAY 08, 2020 10:00 AM PDT
    DATE: May 8, 2020 TIME: 10:00am PT, 11:00am MT, 1:00pm ET The application of next generation sequencing to interrogate immune repertoires and methods in which these highly complex dataset...
    FEB 26, 2020 9:00 AM PST
    C.E. CREDITS
    FEB 26, 2020 9:00 AM PST
    DATE: February 26, 2020 TIME: 9:00am PST 3D cell culture and analysis and the study of organoids and spheroids are becoming more prevalent as a research method in publications as traditional...
    Loading Comments...
    Show Resources
    Attendees
    • See more